x
Ariana Pharma - Logo
[contact-form-7 404 "Not Found"]

  • Paris, FRANCE / Cambridge, MA, USA
  • 666-888-0000
  • info@arianapharma.com
Ariana Pharma - Logo
  • info@arianapharma.com
  • Paris, FRANCE / Cambridge, MA, USA
  • Contact Us
  • Home
  • Our Business
  • Our Technology
  • About Us
  • News
    • In The News
    • Publications
  • Real World Data
  • Careers
Logo

Contact Info

  • 58-60 Avenue de la Grande Armée, 75017, Paris, France
  • +33 1 44 37 17 00
  • info@arianapharma.com
Cancer

Nov2016

Ariana to present on Combination Therapy in Melanoma with Harvard Medical School (Paris | Nov 29 – Dec 2nd)

Dr Parmentier will present a poster “Combination Therapy in Melanoma: finding biomarkers of synergistic associations using Large Scale Drug Combination Screening and integrated Omics Data Analysis” at the Institut Pasteur International Network Scientific Symposium in Paris on November 30th.   The poster showcases the results of a collaborative study between Ariana and the Massachusetts General […]

Read More
Real World Evidence

Nov2016

Ariana to showcase Real World Evidence platform at ASTMH 2016 (Atlanta, USA | Nov 13-17)

Dr David Morley, VP Computational Technology, will be co-presenting a poster at the 65th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH 2016) in Atlanta, USA. Poster 212 “Management of dengue hospitalizations in Brazil during and outside epidemic periods: Insights from Data Mining” is a joint presentation with Sanofi Pasteur and […]

Read More
Alzheimer's

Oct2016

Anavex and Ariana Pharma Collaborate to Accelerate Timelines and Improve Efficiency of Alzheimer’s and Parkinson’s Clinical Development Programs

NEW YORK, NY – October 5, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced a collaboration with Ariana Pharma […]

Read More
Cancer

Sep2016

Ariana Pharma (Paris, Boston) and ValiSeek (London) to collaborate on Phase II Non-small Cell Lung Cancer treatment

Ariana’s advanced data analytics, using its KEM® decision support platform, will help ValiSeek boost success outlook. Ariana® Pharma, a leading digital health Company focused on developing advanced personalized therapeutic decision support systems and a provider of decision support tools and services to accelerate drug development, announces today that it has won a significant contract of […]

Read More
Precision Medicine

Jul2016

Ariana Pharma joins the Healthcare Data Institute

  Ariana is pleased to announce that the company has joined the Healthcare Data Institute. The Healthcare Data Institute is the first international think tank dedicated to Big Data in the health sector. An Orange Healthcare initiative, the Healthcare Data Institute was launched in partnership with other companies representative of the Big Data health ecosystem: […]

Read More
Precision Medicine

Jul2016

Pharma Boardroom interview with Mohammad Afshar

Interview with Mohammad Afshar – CEO, Ariana Pharma, France, 12 July 2016 Mohammad Afshar, CEO of Ariana Pharma, shares his insights on the importance of decision support tools, big data’s impact on the healthcare industry, and the need to translate this data into the production of real products. He also discusses the challenges he faced […]

Read More
Fibromyalgia

Jun2016

Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables

Ariana Pharma and Laboratoires Pierre Fabre have recently published the results of a clinical data mining study using KEM to identify the best responder subgroups for Milnacipran in fibromyalgia. “Is the Efficacy of Milnacipran in Fibromyalgia Predictable? A Data-Mining Analysis of Baseline and Outcome Variables”, Lilia Abtroun, PhD, Pierre Bunouf, PhD, Roger M Gendreau, MD, […]

Read More
Cancer

Jun2016

WIN 2016 Symposium (Paris | June 27-28)

The WIN 2016 Symposium is the place to be to learn about the latest in cancer research by world class presenters. Come and meet the Ariana team of Dr Mohammad Afshar, Dr Guergova-Kuras, Dr Morley and Dr Vaucouleur.

Read More
Precision Medicine

May2016

Ariana Science Day (Paris | May 9)

Ariana hosted their regular Science Day this week – a 1-day symposium in Paris on advances in machine learning and artificial intelligence, chaired by Dr Jean Sallantin, Director of Research at the CNRS LIRMM (Laboratoire d’Informatique, de Robotique et de Micro-électronique de Montpellier) and Scientific Advisor to Ariana.   As ever, this was a stimulating […]

Read More
Precision Medicine

Apr2016

NoFinishLine Paris 2016 (Paris | April 13)

The Ariana Running Team are pleased to participate in the popular NoFinishLine Paris 2016 charitable fun run event in support of sick and homeless children.   Ariana Running Team at NoFinishLine Paris 2016 (Left to right): Sébastien Vaucouleur, Isabelle Chaduteau, Dan Manak, Mohammad Afshar, Yannic Tognetti, Frédéric Parmentier (11254), David Morley, Vincent Récamier, Julie Miralves, […]

Read More

Posts navigation

1 2 3 4 5 6

Categories

  • Alzheimer's
  • Autism
  • Autoimmune disease
  • Cancer
  • Fibromyalgia
  • Kidney Transplant
  • Parkinson’s
  • Precision Medicine
  • Publications
  • Real World Evidence
  • Recent Posts
  • Type A Diabetes
  • Uncategorized

Tags

alzheimer's autism cancer Event Fibromyalgia Graft rejection Influenza Kidney Laboratory lung neurological Parkinson Parkinson’s precisionmedicine precision medicine publication realworldevidence recent post Recent Posts Research Transplant vaccine

Ariana Pharmaceuticals, The AI DRUG Development Company

  • Paris, FRANCE / Cambridge, MA, USA
  • Call Us: +33 144 37 17 00
  • info@arianapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Ariana Pharma © 2022 All Rights Reserved